Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...
Eli Lilly plans to spend $27 billion to build new drug manufacturing sites in the U.S., at a time when President Trump is ...
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® (mirikizumab-mrkz) for the treatment of moderately to severely active ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback